IntOGen-mutations identifies cancer drivers across tumor types.
about
POT1 loss-of-function variants predispose to familial melanomaPractical aspects of NGS-based pathways analysis for personalized cancer science and medicineDiverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and diseaseOncogenomic portals for the visualization and analysis of genome-wide cancer dataCancer evolution: mathematical models and computational inferenceMutational landscape of aggressive cutaneous squamous cell carcinomaThe mutational landscape of endometrial cancerT-cell intracellular antigens in health and diseaseFAM46 proteins are novel eukaryotic non-canonical poly(A) polymerasesImpact of germline and somatic missense variations on drug binding sitesExome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.Protein-structure-guided discovery of functional mutations across 19 cancer typesHarnessing public domain data to discover and validate therapeutic targets.Comprehensive identification of mutational cancer driver genes across 12 tumor types.The mutational landscape of chromatin regulatory factors across 4,623 tumor samples.Unraveling the clonal hierarchy of somatic genomic aberrations.Collection, integration and analysis of cancer genomic profiles: from data to insight.Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysisSeq2pathway: an R/Bioconductor package for pathway analysis of next-generation sequencing data.Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic OpportunitiesHigh number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival.A novel network regularized matrix decomposition method to detect mutated cancer genes in tumour samples with inter-patient heterogeneity.Toward a systematic understanding of cancers: a survey of the pan-cancer studyTranscriptome instability as a molecular pan-cancer characteristic of carcinomasOncodriveROLE classifies cancer driver genes in loss of function and activating mode of actionHuman germline and pan-cancer variomes and their distinct functional profilesMSEA: detection and quantification of mutation hotspots through mutation set enrichment analysisLong-term reduction of T-cell intracellular antigens reveals a transcriptome associated with extracellular matrix and cell adhesion components.Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells.Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours.Protein domain-level landscape of cancer-type-specific somatic mutations.Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.T-cell intracellular antigens function as tumor suppressor genes.OncoRep: an n-of-1 reporting tool to support genome-guided treatment for breast cancer patients using RNA-sequencing.TCF12 is mutated in anaplastic oligodendrogliomaCytoplasmic accumulation of NCoR in malignant melanoma: consequences of altered gene repression and prognostic significanceIntegrated genomics approach to identify biologically relevant alterations in fewer samplesSubclonal diversification of primary breast cancer revealed by multiregion sequencing.The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations.Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.
P2860
Q24563091-AAE6A6D5-5868-4E54-BBFD-D6F2449679A4Q26748603-5E2B2C52-F816-42C4-B106-12C9A626BAFDQ26771889-5F9395F5-5662-4537-8196-2CFAA85EB164Q26781295-4F0257C6-FEC1-45FE-968E-177CC8353114Q27002537-EC5B49F7-4D85-43A4-A981-5116B7861EC8Q27853082-C25D9335-F413-46FA-917A-EE2A93660452Q28084466-86667D5E-48AF-40C1-844B-B45917A85602Q28087308-832F1F36-DD7E-468C-A2E6-C9108F8C0F88Q28603241-81D6A201-7E70-4F28-AF76-CC78B8D4E352Q30383865-6FA4EC1F-7447-4859-B8BF-01BF6E23835DQ30388270-41D89238-DDE0-4935-B100-99E7C44C5E68Q30389229-2C4B9A14-75D4-47FB-9AA1-59579D3AB3F3Q30491667-FBC45F4F-7DC4-4C47-9F25-95CEB00ACAC9Q30547820-F2E776E6-B56E-4145-B647-0A5EFE2553E3Q30580509-3C5AB0EC-E3D5-409D-B674-C67BDE2C8CBFQ30587156-4F6FA4AC-6B13-46D1-BFAA-82CFFDC77C24Q30768176-86D21275-236E-4CB0-804C-19D3F966AA90Q30923212-4BFD87D6-26CB-48EF-A02A-5B9D64B34F44Q30952534-BB4F4BEE-DD18-49D0-BFEE-B5DF4E11748FQ33588151-FE99603F-ACB7-45A6-BF90-04D58C7DFD84Q33742810-FFB43B8C-CB8F-46E9-8E9C-0F15245F2083Q33767347-05FFD504-3FC1-400D-A5DA-D16E3EF377C5Q33840041-7D730B74-ECC0-48BC-A3E7-EF36FC39FE1BQ34041693-06299776-AEF4-49E1-BA3C-30AAEA4BA873Q34103213-E9D24B10-5600-4D80-B138-E15383C81CFBQ34312953-9BA0B7A6-8429-4AFB-AB82-2CA542131318Q34484638-497289FC-726F-46AD-B761-7DAF79D78E49Q34535887-6F6DC6E6-D388-44FD-BA31-603F809E7DF6Q34606469-41073200-231B-4D53-B6C5-CEF0B599815AQ35114280-54AA4E26-044F-4586-A3A0-891FB300CA8BQ35203134-3B702CA6-C03D-40D4-9407-E2BA781BC8EAQ35247152-0CD24508-89A5-48A7-AEB2-CD2F5AAA8112Q35274495-3148EEFC-A097-4FAF-B7A3-B798AF9F7C87Q35635408-7F940ECC-C363-4671-BE50-907658CD8D75Q35813648-273B5F20-B41C-4C77-8D47-78552421467DQ35832342-346E9059-D3EF-4F1B-8590-700F292211A1Q35842440-451476E4-C1F8-4180-B62A-646B7CA038B0Q35847434-3E30E57E-7C83-4E10-AF84-654EA6AFB2EDQ35926110-80692DE3-71EB-4D42-9EE2-A1BAF9A66BDBQ35926362-6AC0E235-73A6-4288-9CBA-5EC8060560AA
P2860
IntOGen-mutations identifies cancer drivers across tumor types.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IntOGen-mutations identifies cancer drivers across tumor types.
@ast
IntOGen-mutations identifies cancer drivers across tumor types.
@en
IntOGen-mutations identifies cancer drivers across tumor types.
@nl
type
label
IntOGen-mutations identifies cancer drivers across tumor types.
@ast
IntOGen-mutations identifies cancer drivers across tumor types.
@en
IntOGen-mutations identifies cancer drivers across tumor types.
@nl
prefLabel
IntOGen-mutations identifies cancer drivers across tumor types.
@ast
IntOGen-mutations identifies cancer drivers across tumor types.
@en
IntOGen-mutations identifies cancer drivers across tumor types.
@nl
P2093
P2860
P50
P356
P1433
P1476
IntOGen-mutations identifies cancer drivers across tumor types
@en
P2093
Alberto Santos
Christian Perez-Llamas
David Tamborero
Jordi Deu-Pons
P2860
P2888
P304
P356
10.1038/NMETH.2642
P577
2013-09-15T00:00:00Z
P5875
P6179
1038149511